FAFTFSNP
BMRN icon

Fjarde AP-fonden (The Fourth Swedish National Pensionfund)’s BioMarin Pharmaceuticals BMRN Stock Holding History

Fjarde AP-fonden (The Fourth Swedish National Pensionfund)’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$6.12M Buy
+74,269
New +$6.18M 0.07% 272

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Fjarde AP-fonden (The Fourth Swedish National Pensionfund)'s BMRN Position: Q2 2024 in Review

Fjarde AP-fonden (The Fourth Swedish National Pensionfund) opened a new position in BioMarin Pharmaceuticals (BMRN) in Q2 2024: 74,269 shares worth $6.12M. The stake represents 0.07% of the portfolio and ranks #272 among its holdings.

559 funds tracked by Wall St. Rank hold BMRN as of Q2 2024.

  • Fjarde AP-fonden (The Fourth Swedish National Pensionfund) held 74,269 shares of BioMarin Pharmaceuticals worth $6.12M as of Q2 2024.
  • BioMarin Pharmaceuticals was a new Fjarde AP-fonden (The Fourth Swedish National Pensionfund) position in Q2 2024.
  • BioMarin Pharmaceuticals made up 0.07% of Fjarde AP-fonden (The Fourth Swedish National Pensionfund)'s portfolio in Q2 2024, its #272 holding.
  • 559 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2024.

Based on Fjarde AP-fonden (The Fourth Swedish National Pensionfund)'s 13F filing for Q2 2024, filed 2 Aug 2024.